XTANT MEDICAL (Germany) Analysis

XTANT Stock Analysis Notes

About 75.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 0.08. XTANT MEDICAL HLDGS had not issued any dividends in recent years. Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana. XTANT MEDICAL operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 110 people. For more information please call the company at 406 388 0480 or visit http://www.xtantmedical.com.

XTANT MEDICAL HLDGS Investment Alerts

XTANT MEDICAL Thematic Classifications

XTANT Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 72.54 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate XTANT MEDICAL's market, we take the total number of its shares issued and multiply it by XTANT MEDICAL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

XTANT Profitablity

The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.1) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.1.

Technical Drivers

As of the 21st of December, XTANT MEDICAL owns the Market Risk Adjusted Performance of 1.1, mean deviation of 3.26, and Information Ratio of (0.07). In relation to fundamental indicators, the technical analysis model lets you check practical technical drivers of XTANT MEDICAL HLDGS, as well as the relationship between them. Please check out XTANT MEDICAL HLDGS standard deviation, maximum drawdown, kurtosis, as well as the relationship between the information ratio and potential upside to decide if XTANT MEDICAL HLDGS is priced some-what accurately, providing market reflects its prevailing price of 0.34 per share.

XTANT MEDICAL HLDGS Price Movement Analysis

XTANT MEDICAL Outstanding Bonds

XTANT MEDICAL Predictive Daily Indicators

XTANT MEDICAL Forecast Models

XTANT MEDICAL's time-series forecasting models are one of many XTANT MEDICAL's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary XTANT MEDICAL's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how XTANT MEDICAL prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling XTANT shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as XTANT MEDICAL. By using and applying XTANT Stock analysis, traders can create a robust methodology for identifying XTANT entry and exit points for their positions.

When running XTANT MEDICAL's price analysis, check to measure XTANT MEDICAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTANT MEDICAL is operating at the current time. Most of XTANT MEDICAL's value examination focuses on studying past and present price action to predict the probability of XTANT MEDICAL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTANT MEDICAL's price. Additionally, you may evaluate how the addition of XTANT MEDICAL to your portfolios can decrease your overall portfolio volatility.